Specifically, 63% of patients receiving semaglutide achieved resolution of steatohepatitis with no worsening of fibrosis, compared with 34% of those on placebo
The semaglutide dosage chart can help visualize the available dose steps
This gastrointestinal issue, known as post-prandial diarrhea, is particularly notable after meals and is more prevalent when certain dietary triggers are involved
The body's weight regulatory systems actively defend against sustained weight loss through multiple mechanisms, including reduced energy expenditure, increased appetite, and enhanced metabolic efficiencyresponses that occur with any significant weight loss method
And a growing body of evidence indicates that many of semaglutides anti-inflammatory and anti-fibrosis actions are independent of blood sugar improvements and weight-loss [1,3], greatly expanding the potential to help non-obese people who have a chronic condition